CJC-1295 (no DAC)
experimentalAlso known as: Mod GRF 1-29, Modified GRF (1-29)
Tetrasubstituted GHRH(1-29) analog with improved enzymatic stability that amplifies pulsatile GH secretion.
Key data
Research & studies
Frequently asked questions
What is CJC-1295 (no DAC)?
Tetrasubstituted GHRH(1-29) analog with improved enzymatic stability that amplifies pulsatile GH secretion.
How does CJC-1295 (no DAC) work?
Tetrasubstituted GHRH(1-29) analog with improved enzymatic stability that amplifies pulsatile GH secretion.
What is the research status of CJC-1295 (no DAC)?
CJC-1295 (no DAC) is currently classified as experimental, with 32 research references on record. This is for research purposes only and is not medical advice.
Related peptides
Endogenous cyclic peptide that inhibits GH, insulin, glucagon, and gastric secretion via SSTR1-5 receptors.
Endogenous 28-aa 'hunger hormone' from the stomach; activates GHS-R1a to stimulate GH release and appetite.
First-generation ghrelin receptor agonist hexapeptide that stimulates GH release and strongly increases appetite.
Potent GHRP-family ghrelin receptor agonist with studied cardioprotective effects independent of GH release.
Synthetic hexapeptide ghrelin receptor agonist that potently stimulates GH secretion; also raises appetite, cortisol, and prolactin.
Stabilized GHRH analog approved for HIV-associated lipodystrophy; reduces visceral adipose tissue via GH/IGF-1 axis stimulation.
Build on CJC-1295 (no DAC) data programmatically
Structured peptide data, semantic search, and AI summaries via one API.
Get a free API key